StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a note issued to investors on Monday. The firm set a “hold” rating on the software maker’s stock.
Separately, Stephens lifted their target price on Veradigm from $7.00 to $13.00 and gave the stock an “equal weight” rating in a report on Friday, January 31st.
Get Our Latest Analysis on Veradigm
Veradigm Stock Performance
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Stories
- Five stocks we like better than Veradigm
- How to Most Effectively Use the MarketBeat Earnings Screener
- How to Build the Ultimate Everything ETF Portfolio
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- What Investors Need to Know About Upcoming IPOs
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
